| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 22:23:14 UTC |
|---|
| Update Date | 2021-09-26 23:17:18 UTC |
|---|
| HMDB ID | HMDB0259635 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide |
|---|
| Description | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide belongs to the class of organic compounds known as phthalimides. These are aromatic heterocyclic compounds containing a 1,3-dioxoisoindoline moiety. They are imide derivatives of phthalic anhydrides. Based on a literature review very few articles have been published on N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-[3-(1,3-dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1h-pyrrole-3-carboxamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC1(C)NC(C)(C)C(=C1)C(=O)NCCCN1C(=O)C2=CC=CC=C2C1=O InChI=1S/C20H25N3O3/c1-19(2)12-15(20(3,4)22-19)16(24)21-10-7-11-23-17(25)13-8-5-6-9-14(13)18(23)26/h5-6,8-9,12,22H,7,10-11H2,1-4H3,(H,21,24) |
|---|
| Synonyms | | Value | Source |
|---|
| N-[3-(1,3-Dioxo-2,3-dihydro-1H-isoindol-2-yl)propyl]-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrole-3-carboximidate | HMDB |
|
|---|
| Chemical Formula | C20H25N3O3 |
|---|
| Average Molecular Weight | 355.438 |
|---|
| Monoisotopic Molecular Weight | 355.189591677 |
|---|
| IUPAC Name | N-[3-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)propyl]-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrole-3-carboxamide |
|---|
| Traditional Name | N-[3-(1,3-dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1(C)NC(C)(C)C(=C1)C(=O)NCCCN1C(=O)C2=CC=CC=C2C1=O |
|---|
| InChI Identifier | InChI=1S/C20H25N3O3/c1-19(2)12-15(20(3,4)22-19)16(24)21-10-7-11-23-17(25)13-8-5-6-9-14(13)18(23)26/h5-6,8-9,12,22H,7,10-11H2,1-4H3,(H,21,24) |
|---|
| InChI Key | QBEQMOQXAHTSRR-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phthalimides. These are aromatic heterocyclic compounds containing a 1,3-dioxoisoindoline moiety. They are imide derivatives of phthalic anhydrides. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Isoindoles and derivatives |
|---|
| Sub Class | Isoindolines |
|---|
| Direct Parent | Phthalimides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phthalimide
- Isoindole
- Pyrroline carboxylic acid or derivatives
- Carboxylic acid imide, n-substituted
- Benzenoid
- Carboxylic acid imide
- Pyrroline
- Secondary carboxylic acid amide
- Amino acid or derivatives
- Carboxamide group
- Azacycle
- Secondary amine
- Carboxylic acid derivative
- Secondary aliphatic amine
- Hydrocarbon derivative
- Organic oxygen compound
- Organic nitrogen compound
- Organonitrogen compound
- Amine
- Organooxygen compound
- Organopnictogen compound
- Carbonyl group
- Organic oxide
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 3.95 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.6347 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.13 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1807.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 175.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 135.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 145.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 64.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 253.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 339.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 130.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 795.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 373.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1118.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 257.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 272.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 247.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 203.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 12.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized| Metabolite | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide | CC1(C)NC(C)(C)C(=C1)C(=O)NCCCN1C(=O)C2=CC=CC=C2C1=O | 4253.5 | Standard polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide | CC1(C)NC(C)(C)C(=C1)C(=O)NCCCN1C(=O)C2=CC=CC=C2C1=O | 3233.5 | Standard non polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide | CC1(C)NC(C)(C)C(=C1)C(=O)NCCCN1C(=O)C2=CC=CC=C2C1=O | 2883.8 | Semi standard non polar | 33892256 |
Derivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,1TMS,isomer #1 | CC1(C)C=C(C(=O)NCCCN2C(=O)C3=CC=CC=C3C2=O)C(C)(C)N1[Si](C)(C)C | 2951.6 | Semi standard non polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,1TMS,isomer #1 | CC1(C)C=C(C(=O)NCCCN2C(=O)C3=CC=CC=C3C2=O)C(C)(C)N1[Si](C)(C)C | 2914.3 | Standard non polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,1TMS,isomer #1 | CC1(C)C=C(C(=O)NCCCN2C(=O)C3=CC=CC=C3C2=O)C(C)(C)N1[Si](C)(C)C | 3564.9 | Standard polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,1TMS,isomer #2 | CC1(C)C=C(C(=O)N(CCCN2C(=O)C3=CC=CC=C3C2=O)[Si](C)(C)C)C(C)(C)N1 | 2893.1 | Semi standard non polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,1TMS,isomer #2 | CC1(C)C=C(C(=O)N(CCCN2C(=O)C3=CC=CC=C3C2=O)[Si](C)(C)C)C(C)(C)N1 | 2732.9 | Standard non polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,1TMS,isomer #2 | CC1(C)C=C(C(=O)N(CCCN2C(=O)C3=CC=CC=C3C2=O)[Si](C)(C)C)C(C)(C)N1 | 3443.1 | Standard polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,2TMS,isomer #1 | CC1(C)C=C(C(=O)N(CCCN2C(=O)C3=CC=CC=C3C2=O)[Si](C)(C)C)C(C)(C)N1[Si](C)(C)C | 2981.3 | Semi standard non polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,2TMS,isomer #1 | CC1(C)C=C(C(=O)N(CCCN2C(=O)C3=CC=CC=C3C2=O)[Si](C)(C)C)C(C)(C)N1[Si](C)(C)C | 2871.3 | Standard non polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,2TMS,isomer #1 | CC1(C)C=C(C(=O)N(CCCN2C(=O)C3=CC=CC=C3C2=O)[Si](C)(C)C)C(C)(C)N1[Si](C)(C)C | 3421.8 | Standard polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,1TBDMS,isomer #1 | CC1(C)C=C(C(=O)NCCCN2C(=O)C3=CC=CC=C3C2=O)C(C)(C)N1[Si](C)(C)C(C)(C)C | 3154.3 | Semi standard non polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,1TBDMS,isomer #1 | CC1(C)C=C(C(=O)NCCCN2C(=O)C3=CC=CC=C3C2=O)C(C)(C)N1[Si](C)(C)C(C)(C)C | 3117.9 | Standard non polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,1TBDMS,isomer #1 | CC1(C)C=C(C(=O)NCCCN2C(=O)C3=CC=CC=C3C2=O)C(C)(C)N1[Si](C)(C)C(C)(C)C | 3631.9 | Standard polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,1TBDMS,isomer #2 | CC1(C)C=C(C(=O)N(CCCN2C(=O)C3=CC=CC=C3C2=O)[Si](C)(C)C(C)(C)C)C(C)(C)N1 | 3091.5 | Semi standard non polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,1TBDMS,isomer #2 | CC1(C)C=C(C(=O)N(CCCN2C(=O)C3=CC=CC=C3C2=O)[Si](C)(C)C(C)(C)C)C(C)(C)N1 | 2944.6 | Standard non polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,1TBDMS,isomer #2 | CC1(C)C=C(C(=O)N(CCCN2C(=O)C3=CC=CC=C3C2=O)[Si](C)(C)C(C)(C)C)C(C)(C)N1 | 3537.9 | Standard polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,2TBDMS,isomer #1 | CC1(C)C=C(C(=O)N(CCCN2C(=O)C3=CC=CC=C3C2=O)[Si](C)(C)C(C)(C)C)C(C)(C)N1[Si](C)(C)C(C)(C)C | 3380.6 | Semi standard non polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,2TBDMS,isomer #1 | CC1(C)C=C(C(=O)N(CCCN2C(=O)C3=CC=CC=C3C2=O)[Si](C)(C)C(C)(C)C)C(C)(C)N1[Si](C)(C)C(C)(C)C | 3268.4 | Standard non polar | 33892256 | | N-[3-(1,3-Dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide,2TBDMS,isomer #1 | CC1(C)C=C(C(=O)N(CCCN2C(=O)C3=CC=CC=C3C2=O)[Si](C)(C)C(C)(C)C)C(C)(C)N1[Si](C)(C)C(C)(C)C | 3555.2 | Standard polar | 33892256 |
|
|---|